Skip to content

Anthem Biosciences Ltd. IPO

MAINBOARD · LISTED

Listed on 21 Jul 2025 at ₹723.05(26.85% above the issue price)

First-day close ₹730.35, 28.13% above the issue price of ₹570.

Finfod Research DeskUpdated 12 Nov 2026How we check

STATUS

Listed

ISSUE

₹570

LISTING

₹723.05+26.85%

LAST GMP

₹179

Anthem Biosciences IPO GMP

Last GMP → listingUnofficial
₹179→₹723.05

GMP pointed to ₹749, listed at ₹723.05, ₹25.95 below last check.

+31.40% vs the issue price of ₹570

GMP vs listingListed below last check
A day-wise chart will show when more than one unofficial check is recorded.
Last GMP checked 21 Jul 2025, 10:00 am IST. Listed 21 Jul 2025.Grey market premium is unofficial and not a guarantee of listing price.
On this page11 sections

Official links

How to apply

Use UPI and ASBA. The guide covers the close, allotment, and the T+3 listing.

Open the guide

Related guides

Anthem Biosciences IPO listing price

Listed at ₹723.05 on 21 Jul 2025.

Listing price
₹723.05
Last pre-listing GMPGMP means grey market premium. It is an unofficial price before listing, not the issue price.
₹179 (checked 21 Jul 2025, 10:00 am IST). Unofficial
Close on listing day
₹730.35

The listing gain versus the issue price of ₹570 is ₹153.05 above it (26.85%).

The grey market was ₹179, which pointed to ₹749. The listing was ₹25.95 below that.

The grey market premium is unofficial.

Anthem Biosciences IPO subscription status

Subscribed 67.42× overall. Final, as of 16 Jul 5 pm IST.

  • Total

    67.42×

Anthem Biosciences IPO lot size and application limits

Application amounts calculated at the upper price band (cap price of ₹570). Retail applications are capped at ₹2,00,000 by SEBI rules.

ApplicationLotsSharesAmount
Retail (Min)1 lot26 shares₹14,820
Retail (Max)13 lots338 shares₹1,92,660
Small HNI (sNII Min)14 lots364 shares₹2,07,480
Small HNI (sNII Max)67 lots1,742 shares₹9,92,940
Big HNI (bNII Min)68 lots1,768 shares₹10,07,760

Dates

  1. Opens

    14 Jul 2025

  2. Closes

    16 Jul 2025

  3. AllotmentAllotment is the decision of who gets shares after the issue closes. Basis of allotment, in the glossary

    17 Jul 2025

  4. Refunds

    18 Jul 2025

  5. Demat credit

    18 Jul 2025

  6. Listing

    21 Jul 2025

About this company and offer

Anthem Biosciences Ltd. IPO is listed. It opened on 14 Jul 2025 and closed on 16 Jul 2025. It listed on 21 Jul 2025. The price band is ₹540 to ₹570. One lot is 26 shares, and the minimum amount is ₹14,820 for 1 lot. The issue size is ₹3,395 crore, with a fresh issue of ₹0 crore and an offer for sale of ₹3,395 crore. In FY25, revenue from operations was ₹1,930.29 crore and profit after tax was ₹451.26 crore. Revenue from operations was up 30.2% from ₹1,483.07 crore in FY24. Profit after tax was up 22.9% from ₹367.31 crore in FY24.

The grey market premium shown for Anthem Biosciences Ltd. is ₹179. Grey market premium is unofficial and not a guarantee of listing price.

The total subscription for Anthem Biosciences Ltd. is 67.42 times.

Anthem Biosciences Ltd. listed at ₹723.05.

Anthem Biosciences is a contract research, development and manufacturing company that works with pharmaceutical and biotechnology clients.

Promoters

Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj

Reservation

Retail
35%
Large bidsNII means a bid bigger than the retail limit, and not from a big institution. How allotment works
15%
Big fundsQIB means a big institution, such as a mutual fund or a bank. How allotment works
50%

Financials

₹ crore, for the last three reported years.

Revenue from operations and profit

Each chart has its own scale. Amounts are in ₹ crore.

Revenue from operations

₹1,134 cr₹1,483 cr₹1,930 cr
Revenue from operations
YearRevenue from operations
FY23₹1,134 cr
FY24₹1,483 cr
FY25₹1,930 cr
FY23FY24FY25

Profit after tax

₹385 cr₹367 cr₹451 cr
Profit after tax
YearProfit after tax
FY23₹385 cr
FY24₹367 cr
FY25₹451 cr
FY23FY24FY25
Revenue from operations and profit after tax, in ₹ crore
YearRevenue from operationsProfit
FY23₹1,133.99 crore₹385.19 crore
FY24₹1,483.07 crore₹367.31 crore
FY25₹1,930.29 crore₹451.26 crore

Net worth

₹ crore, for each year that reports net worth.

Net worth in ₹ crore
YearNet worth
FY23₹1,740.67 crore
FY24₹1,924.66 crore
FY25₹2,409.86 crore
FY23FY25
Net worth in ₹ crore
YearNet worth
FY23₹1,740.67 crore
FY24₹1,924.66 crore
FY25₹2,409.86 crore
YearRevenue from operationsPATNet worthAssetsBorrowings
FY231,133.99385.191,740.67——
FY241,483.07367.311,924.66——
FY251,930.29451.262,409.86——

Issue structure

Offer for sale

₹3,395 crore Fresh issue ₹0 crore

Reservation

Share kept for each group. The percents are the published figures.

Reservation
PartAmount
Retail35%
Large bids15%
Big funds50%
Reservation
PartAmount
Retail35%
Large bids15%
Big funds50%

Issue

Face value
₹2
Fresh issue
₹0 crore
Offer for saleOFS means offer for sale. Existing owners are selling shares. The company does not get that money.
₹3,395 crore
Exchanges
BSE, NSE
Registrar
Kfin Technologies Ltd.

Frequently asked questions

What is the Anthem Biosciences Ltd. IPO date?

It opened on 14 Jul 2025 and closed on 16 Jul 2025.

What is the price band of Anthem Biosciences Ltd. IPO?

The price band is ₹540 to ₹570. One lot is 26 shares, and the minimum amount is ₹14,820 for 1 lot.

What is the last GMP of Anthem Biosciences Ltd. IPO?

The unofficial grey market premium is ₹179 as of 21 Jul 2025, 10:00 am IST. The grey market is unofficial.

How do I check Anthem Biosciences Ltd. IPO allotment status?

Allotment was on 17 Jul 2025. You can check allotment status online using the registrar portal linked on this page.

How many times was Anthem Biosciences Ltd. IPO subscribed?

Total subscription is 67.42 times, checked 16 Jul 2025, 5:00 pm IST.

What is the Anthem Biosciences Ltd. IPO listing price?

The listing price was ₹723.05 with a listing gain of 26.85% against the upper band of ₹570.

What is the issue size of Anthem Biosciences Ltd. IPO?

The issue size is ₹3,395 crore, with a fresh issue of ₹0 crore and an offer for sale of ₹3,395 crore.

This page is a calendar of dates and prices. It is not a recommendation to apply.